Table 4 Subgroup analysis of occurrence of MACEs.
Subgroups | N | HR | 95%CI | P value |
|---|---|---|---|---|
Total | 1938 | 1.603 | (1.134,2.266) | 0.007 |
Male | ||||
0 | 577 | 1.015 | (0.523,1.968) | 0.966 |
1 | 1361 | 1.983 | (1.318,2.985) | 0.001 |
Vascular occlusion | ||||
0 | 1398 | 1.711 | (1.098,2.667) | 0.018 |
1 | 540 | 1.335 | (0.751,2.372) | 0.325 |
multivessel disease | ||||
0 | 165 | 23.979 | (4.473,128.560) | < 0.001 |
1 | 1773 | 1.402 | (0.974,2.017) | 0.069 |
CCB/ARB/ACEI | ||||
0 | 757 | 1.722 | (0.894,3.315) | 0.104 |
1 | 1181 | 1.593 | (1.054,2.408) | 0.027 |
Statins | ||||
0 | 127 | 1.619 | (0.753,3.480) | 0.217 |
1 | 1811 | 1.513 | (1.029,2.226) | 0.035 |
FPG | ||||
< 6.1 | 1172 | 1.728 | (1.064,2.808) | 0.027 |
6.1–7.0 | 291 | 1.862 | (0.864,4.013) | 0.112 |
≥ 7.0 | 475 | 1.142 | (0.588,2.216) | 0.695 |
LDL-C | ||||
< 1.8 | 242 | 2.416 | (0.583,10.010) | 0.224 |
1.8–2.6 | 682 | 1.868 | (0.719,4.856) | 0.200 |
≥ 2.6 | 1014 | 2.043 | (1.306,3.197) | 0.002 |